PRF Technologies Ltd. (PRFX)
Automate Your Wheel Strategy on PRFX
With Tiblio's Option Bot, you can configure your own wheel strategy including PRFX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRFX
- Rev/Share 0.0
- Book/Share 99.423
- PB 0.0298
- Debt/Equity 0.0066
- CurrentRatio 1.5916
- ROIC -0.4715
- MktCap 238375.0
- FreeCF/Share -70.1837
- PFCF -0.04
- PE -0.0615
- Debt/Assets 0.005
- DivYield 0
- ROE -0.7959
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy
Published: January 20, 2026 by: GlobeNewsWire
Sentiment: Neutral
Patent filing follows acceptance into the NVIDIA Connect Program Proprietary software targets weather forecast-driven revenue optimization, reduced penalty risk, and improved market performance for utility-scale solar assets TEL AVIV, Israel, Jan. 20, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) (formerly “PainReform”) today announced that it has filed a patent application covering proprietary methods for solar plant–level micro-climate modeling designed to significantly improve the accuracy of solar energy production forecasts in competitive electric utility markets.
Read More
PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push
Published: January 16, 2026 by: Benzinga
Sentiment: Positive
Penny stock PainReform Ltd. (NASDAQ: PRFX) stock climbed on Friday following the company's recent announcement of a name change to PRF Technologies Ltd.
Read More
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy
Published: December 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
Development plan positions OcuRing™-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery market Development plan positions OcuRing™-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery market
Read More
PainReform Provides Business Update for the Six Months Ended June 30, 2025
Published: October 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today provided a business update for the six months ended June 30, 2025.
Read More
Nvidia enrollment sends this stock soaring 130%
Published: August 19, 2025 by: Finbold
Sentiment: Positive
Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program.
Read More
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
Published: May 27, 2025 by: PRNewsWire
Sentiment: Neutral
As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost TEL AVIV, Israel , May 27, 2025 /PRNewswire/ -- Blade Ranger Ltd. (TASE: BLRN), a company listed on the Tel Aviv Stock Exchange, announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform (NASDAQ: PRFX).
Read More
PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
Published: March 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation Acquisition Positions PainReform as a Potential Leader in High-Growth, High-Margin AI Solar Energy Management While Continuing Its Core Focus on Pharmaceutical Innovation
Read More
About PRF Technologies Ltd. (PRFX)
- IPO Date 2020-09-01
- Website https://prf-tech.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Ehud Geller
- Employees 2